U.S. Consumer Finance Stock News

Goldman Sachs (NYSE:GS) has led major funding rounds in Aidoc, a clinical AI platform, and Hightouch, an AI-driven marketing automation provider. The alternatives unit at Goldman Sachs anchored a US$150 million round for Aidoc and a fundraising round above US$150 million for Hightouch. These transactions expand the bank's exposure to enterprise AI and digital transformation across healthcare and marketing technology. For you as an investor, these moves show how Goldman Sachs is leaning...

If you are wondering whether Amazon.com at US$265.06 is still reasonably priced or already reflecting a lot of optimism, this breakdown will help you frame that question clearly. The stock has recorded returns of 3.9% over the last 7 days, 27.3% over the last 30 days, 17.0% year to date and 39.4% over the last year. This naturally raises questions about how much value is already reflected in the price. Recent news coverage has focused on Amazon.com's broad role across e commerce, cloud...

Why Huntsman’s latest earnings matter for shareholders Huntsman (HUN) just reported first quarter 2026 results, with sales of US$1,420 million and a net loss of US$53 million, compared with a US$5 million loss a year earlier. See our latest analysis for Huntsman. Huntsman’s 1-day share price return of 8.45% and year to date share price return of 41.02% suggest momentum has picked up recently. However, the 5 year total shareholder return of a 43.55% decline points to a weaker longer run...

Coca-Cola (NYSE:KO) reported Q1 2026 earnings that outperformed prior expectations and raised its full year profit outlook. The company highlighted rapid growth in its zero sugar and premium product lines, with Coca-Cola Zero Sugar delivering double digit growth as a key product success. Management pointed to continued resilience in the face of geopolitical disruption and differences in consumer spending patterns across markets. Coca-Cola is preparing for a major shift in H2 2026 with the...

If you are wondering whether Analog Devices at around US$402 per share looks expensive or attractive, the answer depends on how you think about value, not just price. The stock has been volatile recently, with a 0.4% decline over the last 7 days, but a 26.4% gain over 30 days, 46.9% year to date, and returns of 110.8% over 1 year, 133.3% over 3 years, and 182.1% over 5 years. Recent coverage has focused on Analog Devices as a key name in semiconductors, with attention on how its technology...

Recent share performance snapshot Manchester United (NYSE:MANU) has seen its share price move recently, with a last close of US$18.88. Over the past month and the past 3 months, the stock has recorded total returns of 12.2% and 6.7% respectively. See our latest analysis for Manchester United. For context, the recent 1 month share price return of 12.2% and year to date share price return of 19.65% sit alongside a 1 year total shareholder return of 37.11%, while the 3 year total shareholder...

The Bank of N.T. Butterfield & Son Limited ( NYSE:NTB ) just released its latest quarterly results and things are...

Hayward Holdings, Inc. ( NYSE:HAYW ) defied analyst predictions to release its quarterly results, which were ahead of...

Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) just released its first-quarter report and things are looking bullish. The...

Why a potential short squeeze is putting Asana (ASAN) on watch Asana (ASAN) is drawing renewed attention after analysis highlighted short interest above 30% and a relatively tight float, given founder Dustin Moskovitz’s large controlling stake. Together, these factors raise the potential for a short-squeeze setup. See our latest analysis for Asana. Despite renewed interest around a potential short squeeze and recent board changes taking effect at the June 2026 annual meeting, Asana’s 1-year...

Lumen Technologies announced that Executive Vice President and Chief Legal Officer & Head of Public Sector Mark Hacker has retired to pursue ministry, with Senior Vice President Jennifer Hodges promoted to Executive Vice President and Chief Legal Officer and Jeff Sharritts assuming Public Sector responsibilities as of April 20, 2026. This reshuffle consolidates legal, governance, and public sector oversight under leaders with deep corporate and telecom experience, potentially influencing how...

Hycroft Mining Holding (HYMC) is back in focus after Q1 2026 results highlighted a 55% increase in measured and indicated gold and silver resources, alongside continued work on underground mining options in Nevada. See our latest analysis for Hycroft Mining Holding. The stock has been volatile around these updates, with a 6.6% 1 day share price return and a 49.4% year to date share price return, while the 1 year total shareholder return is very large. Recent exploration and resource news...

Blackstone (NYSE:BX) committed up to US$400 million to Teva's autoimmune drug program in a recent life sciences deal. The firm also arranged a US$2 billion, utility backed power financing package for QTS data centers to support AI focused capacity. These transactions sit alongside Blackstone's traditional alternatives platform and indicate additional sector exposure in health and digital infrastructure. For investors, these moves illustrate how NYSE:BX is putting capital to work in areas...

Q1 earnings and dividend decision set the tone for Webster Financial Webster Financial (WBS) has just combined fresh first quarter 2026 results with a reaffirmed cash dividend, giving you updated information on earnings quality, balance sheet trends, and ongoing capital returns. See our latest analysis for Webster Financial. Webster Financial's recent first quarter earnings and dividend announcement come after a 10.02% 90 day share price return and a 55.60% total shareholder return over the...

ON Semiconductor (ON) is back in focus after deepening its collaborations with automakers Geely and NIO, which are integrating the company’s EliteSiC power technologies into high voltage electric vehicle platforms. See our latest analysis for ON Semiconductor. These EV collaborations are landing at a time when momentum in ON Semiconductor’s shares is already strong, with a 30 day share price return of 62.81% and a 1 year total shareholder return of 154.57% pointing to shifting expectations...

If you are wondering whether Navan is fairly priced or offering hidden value at its current level, it helps to look beyond the headline share price and into what different valuation methods are signaling. Navan’s stock recently closed at US$17.49, with returns of 12.9% over the past 7 days, 32.1% over the past 30 days, and 7.6% year to date. This performance has likely caught the attention of investors watching for changes in sentiment and risk appetite. These moves sit against a backdrop...

Royalty Pharma plc recently approved a second-quarter 2026 dividend of US$0.235 per Class A ordinary share, payable on June 10, 2026, to shareholders of record as of May 15, 2026. This dividend affirmation, alongside increased analyst optimism around upcoming first-quarter 2026 earnings, highlights Royalty Pharma’s focus on cash returns while markets reassess its royalty-driven model and risk profile. We’ll now examine how the confirmed Q2 2026 dividend supports Royalty Pharma’s investment...

Kadant has completed the acquisition of voestalpine BÖHLER Profil, which has been renamed Kadant Profil. The deal expands Kadant’s product portfolio and international manufacturing footprint within its Industrial Processing segment. The transaction adds advanced R&D capabilities and industrial knife solutions to Kadant’s offering. Kadant (NYSE:KAI), recently trading around $293.13, has seen mixed share performance, with a 10.2% decline over the past week and a 2.3% gain year to date. Over...

Entergy (ETR) opened 2026 with Q1 revenue of US$3.2b and basic EPS of US$0.84, against a trailing twelve month EPS figure of US$3.98 that reflects earnings growth of 32.9% over the past year. Over the last five reported quarters, revenue has ranged from US$2.7b to US$3.8b while quarterly EPS has moved between US$0.52 and US$1.55, giving investors a clear view of how the top and bottom lines have tracked through recent periods. With trailing net profit margin now at 13.4% compared with 11.2% a...

This article examines whether Sensata Technologies Holding, at around US$41.64, is priced for further upside or already reflects most of its story, focusing squarely on what the numbers indicate about value. The stock has returned 18.2% over the last 30 days and 97.8% over the past year. The year-to-date return is 19.3%, while the 5-year return is a 24.0% decline. Recent coverage has highlighted the stock's strong 1-year return of 97.8% and contrasted that with its weaker 5-year record. This...

Angelini Pharma is reportedly exploring a potential acquisition of Catalyst Pharmaceuticals, NasdaqCM:CPRX. The rumors center on a possible takeover that could affect Catalyst Pharmaceuticals' valuation and control. The news comes as Catalyst Pharmaceuticals shares last closed at $28.13. Catalyst Pharmaceuticals has delivered strong multi year share returns, with the stock up 21.5% year to date and 15.9% over the past year. Looking further back, investors holding over three and five years...

In April 2026, activist investor Summer Road LLC won a contested proxy battle at Ingles Markets, with its nominee Rory A. Held elected to the board following a heated campaign over governance, disclosure, and capital allocation. The result marks a rare successful challenge to a family-influenced grocer’s board, signaling that shareholders were willing to back an outsider aligned with concerns over Ingles’ underused real estate and transparency. We’ll now examine how this board shake-up, and...

If you are wondering whether Veeva Systems at around US$155.97 is starting to look attractively priced, you are not alone. The share price has been under pressure, with a 0.1% slip over the past week, an 11.2% decline over 30 days, a 28.9% decline year to date, and a 32.8% decline over the last year. Recent headlines have focused on how Veeva Systems is positioned within healthcare software and its ability to support life sciences companies with regulated data and workflows. This context...

If you are wondering whether China Yuchai International at around US$41.21 still offers value or if most of the opportunity is already priced in, the starting point is to understand what the recent share price action really reflects. The stock has returned 7.0% over the past 30 days, 11.3% year to date and 175.6% over the last year, while the very large 3 year return and 222.6% 5 year return suggest long term holders have experienced a strong ride through different market conditions. Recent...